Immunoglobulin complex preparation, or simply "KIP", the instructions for use define it as an immunostimulating drug designed to increase specific immunity. This tool significantly increases the content of antibodies to enteroviruses and enterobacteria such as salmonella, shigella and escherichia. In addition, the drug "KIP", the price of which is about seven hundred rubles, effectively increases the amount of immunoglobulins contained in the blood. At the same time, the manufacturing company emphasizes that this drug does not contain antibiotics or preservatives. The immunobiological characteristics of this drug are directly related to the presence of IgA, IgG and IgM.
Composition of the drug and release form
The drug "KIP" is produced (instructions for use are in each package) in the form of a lyophilisate intended for preparationsolution for further oral administration. The concentrate itself is an amorphous mass of blue or white. The composition of this immunostimulating agent as the main element includes three hundred milligrams of human immunoglobulin. Glycine acts as an auxiliary ingredient. The latter is contained in a volume of one hundred milligrams.
List of indications for use
Prescribe the remedy "KIP" instructions for use advise people who suffer from acute forms of intestinal infections and dysbacteriosis that developed after undergoing a course of chemotherapy or as a result of the negative effects of radiation. In addition, this drug is quite actively used during immunocorrective therapy in young patients. So, it recommends taking the "KIP" remedy for use in children with poor he alth, premature babies, as well as those babies who are bottle-fed. In addition, this drug is indicated for use in order to prevent the development of infectious diseases in people with the so-called acquired immunodeficiency and in people who have a reduced immune status (the elderly, the disabled).
Contraindications and precautions
Assign the tool "KIP" instructions for use categorically prohibits patients suffering from individual intolerance to glycine. People with an allergic reaction to immunoglobulin should also stop using thisimmunostimulatory drug. True, in some cases, treatment can be continued using antihistamines. In addition, the drug should not be used in the absence of mandatory labeling of the vial containing the lyophilisate, in case of violation of its integrity, in case of changes in physical properties or the presence of any foreign inclusions. If the temperature storage regime established by the manufacturer is not observed, this immunostimulating agent should also not be used.
